Gut microbiota and neonatal acute kidney injury biomarkers.
One of the most frequent issues in newborns is acute kidney injury (AKI), which can lengthen their hospital stay or potentially raise their chance of dying. The gut–kidney axis establishes a bidirectional interplay between gut microbiota and kidney illness, particularly AKI, and demonstrates the imp...
| Publicado en: | Pediatric Nephrology Vol. 38; no. 11; pp. 3529 - 3548 |
|---|---|
| Autores principales: | , , , , |
| Formato: | pictorial review tables/charts Journal Article |
| Publicado: |
Springer Nature
Nov2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| Sumario: | One of the most frequent issues in newborns is acute kidney injury (AKI), which can lengthen their hospital stay or potentially raise their chance of dying. The gut–kidney axis establishes a bidirectional interplay between gut microbiota and kidney illness, particularly AKI, and demonstrates the importance of gut microbiota to host health. Since the ability to predict neonatal AKI using blood creatinine and urine output as evaluation parameters is somewhat constrained, a number of interesting biomarkers have been developed. There are few in-depth studies on the relationships between these neonatal AKI indicators and gut microbiota. In order to gain fresh insights into the gut–kidney axis of neonatal AKI, this review is based on the gut–kidney axis and describes relationships between gut microbiota and neonatal AKI biomarkers. |
|---|